[{"Assets_0_Q2_USD":4169941000.0,"CommonStockSharesOutstanding_0_Q2_shares":163314091.0,"EarningsPerShareBasic_1_Q2_USD":-1.29,"EarningsPerShareBasic_2_Q2_USD":-1.85,"EarningsPerShareDiluted_1_Q2_USD":-1.29,"EarningsPerShareDiluted_2_Q2_USD":-1.85,"NetIncomeLoss_1_Q2_USD":-209536000.0,"NetIncomeLoss_2_Q2_USD":-300106000.0,"StockholdersEquity_0_Q2_USD":1028768000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":162931930.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":162486946.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":162931930.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":162486946.0,"Ticker":"HZNP","CIK":"1492426","name":"HORIZON PHARMA PLC","OfficialName":"Horizon Therapeutics Public Limited Company Ordinary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26299872538.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]